CD40LG and B-cell chronic lymphocytic leukemia: In principle, viral gene transfer of CD154 into B-CLL cells is a suitable approach to induce immunological reactions both in vitro and in vivo[14], [26]–[29] but the low transduction efficiency and the resulting high dose of viral vectors may induce severe side effects.